New York, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on September 4, 2025, it caused to be deposited $0.15 per public share, totaling $10,890.15 (the “Extension Payment”) into its trust account (the “Trust Account”) with Continental Stock Transfer and Trust Company (“Continental”) to extend the deadline to complete its initial business combination from Septe ...

EB613 Demonstrates Significant Effects on Both Trabecular and Cortical Bone Compartments After Just 6 Months of Treatment in Phase 2 Study; Cortical Improvements Comparable to Injectable Teriparatide and Abaloparatide Company Plans to Initiate Global Registrational Phase 3 Study Following July 2025 FDA Concurrence Entera also Presented Promising Pharmacokinetic Data for Next-Gen EB613 Single Tablet Candidate as Potential Future Franchise Extension JERUSALEM, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Lt ...

Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the CompanyCHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has completed the evaluation of strategic alternatives for its Wellspect Healthcare business (“Wellspect”), which was announced in February 2025. As a part of its review process, Dentsply Sirona considered a range of potential opportuni ...

OLD GREENWICH, Conn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR and STRRP) (“Star” or the “Company”), a diversified holding company, announced today that its wholly owned subsidiary, Hudson RPO, operating inside its Business Services division, has rebranded to Hudson Talent Solutions (“HTS”), reflecting the business’ broadened vision and expanded global capabilities. The rebrand is accompanied by the launch of a new website, www.hudsontalent.com. The change is the culminati ...

Financial Performance - For the three months ended June 30, 2025, the company reported a net income of $13.7 million, an increase of $3.0 million or 28.0% compared to the same period in 2024 [18] - Adjusted net income for the same period was $14.5 million, up $2.1 million or 16.9% year-over-year [19] - Voyage revenues increased to $38.6 million, a rise of $1.0 million or 2.7% from the previous year [20] Operational Metrics - The company achieved a fleet utilization rate of 99.4% for the three months ended June 30, 2025, compared to 100% in the same period of 2024 [21] - Average daily hire gross of commissions was approximately $70,730 per day per vessel, down from $72,010 in the prior year [21] - The company maintained a strong contract backlog estimated at approximately $0.9 billion with an average remaining contract duration of 5.4 years [11][32] Cash Flow and Liquidity - The company generated net cash from operating activities of $24.3 million for the three months ended June 30, 2025, an increase of $1.8 million or 8.0% from the same period in 2024 [28] - As of June 30, 2025, the cash balance stood at $77.9 million, with no debt maturities until mid-2029 [14][13] - The company redeemed all 2,200,000 Series B Preferred Units for a total payment of $56.0 million, funded by internal cash reserves [30] Debt and Financing - The company reported total outstanding debt of $300.8 million, with annual debt amortization of $44.2 million, representing 14.6% of total debt [13] - Net interest and finance costs decreased to $5.2 million for the three months ended June 30, 2025, down 36.6% from $8.2 million in the same period of 2024 [24] Market Environment - The company remains insulated from short-term volatility in the LNG market due to its contracts-based business model [10] - Current U.S. and E.U. sanctions related to the Russian conflict do not materially affect the company's operations or financial condition [16]

Spain site opens with two R/R AML subjects enrolled; One treated On track to recruit 45 subjects in 4Q25 for initial data unblinding HOUSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced that it has enrolled the first two subjects, and treated one, in the European Union (EU) in its pivotal Phase 2B/3, ...

Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable path forward for Zynquista NDA resubmission FDA feedback from Type D meeting expected by end of September THE WOODLANDS, Texas, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the Company has submitted additional clinical data to the U.S. Food and Drug Adminis ...

VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report its participation in the NSC Safety Congress & Expo, taking place September 15–17, 2025 in Denver, Colorado. The NSC Safety Congress & Expo is the world’s largest annual event dedicated to workplace safety, health, and environmental professionals and will have thousan ...

Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European UnionMARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that the company has received CE mark approval for the ReWalk 7 Personal Exoskeleton, clearing it for commercial sale in ...

NEW PORT RICHEY, Fla., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a Florida-based provider of residential solar and commercial long-duration energy-storage solutions, today announced that the Company will be presenting at ROTH Capital’s 12th Annual Solar & Storage Symposium on Tuesday, September 9, at the upcoming RE+ trade show in Las Vegas, Nevada, which runs from September 8-11, 2025. The symposium, hosted by ROTH Capital during RE+, provide ...